(Q53503496)

English

Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

0 references

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

Nilufar Mossaheb

4

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

Rupert Lanzenberger

6

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

Siegfried Kasper

12

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

author name string

Nikolas Klein

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

Thomas Geiss-Granadia

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

Trawat Attarbaschi

5

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

Christoph Spindelegger

7

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

Alexander Holik

8

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

Susanne Asenbaum

9

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

Robert Dudczak

10

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

Johannes Tauscher

11

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

publication date

19 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

191

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

333-339

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unique mechanism of action for escitalopram: does it hold the promise?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escitalopram: a review of its use in the management of major depressive disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time course of in vivo 5-HTT transporter occupancy by fluvoxamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escitalopram versus citalopram: the surprising role of the R-enantiomer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of citalopram effect on oral digoxin pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significant dissociation of brain and plasma kinetics with antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic consequences of a citalopram treatment discontinuation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAM.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17235610

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-006-0666-Y

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/17235610

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53503496&oldid=2212157544"